Floatz logo

TECHNETIUM TC 99M PYROPHOSPHATE

Heart Failure With Preserved Ejection Fraction

Mayo ClinicSmall moleculeEarly Phase 1Dormant
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
89/ 100

Competitive context

18 Active assets in the Heart Failure With Preserved Ejection Fraction cohort.

Asset / SponsorPhaseRating
Semaglutide
Mayo Clinic
Phase 4BBB
Metformin
Sara ElAdawy
Phase 4BBB
Tirzepatide
Yunlong Wang
Phase 4BBB
Liraglutide
Leiden University Medical Center
Phase 4BBB
BENZBROMARONE
National Defense Medical Center, Taiwan
Phase 4BB

View all 23 →

Same molecule, other indications

TECHNETIUM TC 99M PYROPHOSPHATE is also rated in:

amyloidosisDormant
CC
Indicative ·
43 / 100
View asset →
aortic valve stenosisDormant
CC
Indicative ·
43 / 100
View asset →
Transthyretin AmyloidosisDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →